AHB-137 trials for Hepatitis B

All AHB-137 trials · All Hepatitis B trials

Phase breakdown

Recruiting trials studying AHB-137 for Hepatitis B

• A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
  NCT07069569 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 14 locations
• A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
  NCT07635186 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 34 locations
• A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
  NCT07137910 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations
• Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
  NCT07370207 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations
• Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
  NCT07654283 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations

Common questions

How many trials study AHB-137 for Hepatitis B?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.